Abstract
Introducing an intelligent pharmaceutical nanocarrier for targeted drug release and reducing the side effects of chemotherapy is the main goal of many researchers. In this area, we synthesized amphiphilic triblock copolymer PCL-ss-PEG-ss-PCL consisting of cystamine as a reduction sensitive linkage. The aqueous self-assembly of triblock copolymer in the presence of magnetic iron oxide nanoparticles (Fe3O4) and doxorubicin (DOX) led to the formation of reduction-sensitive flower like magnetomicelle containing DOX and Fe3O4. The innovative design based on intelligent flower like structure led to high drug loading content, reduce drug release in physiologic condition, fast degradation at targeted site and burst release of more content of drug at earlier time. The DOX loading content was about 19% and DOX- loaded magnetomicelles (D-LMM) showed more triggered release under redox conditions at pH = 5. The efficiency of D-LMM was compared with non-reduction sensitive control group (CD-LMM), free DOX and commercial product of liposomal DOX (LD) in vitro. The D-LMM showed significant improvement in cellular uptake and toxicity behavior on human breast adenocarcinoma MCF-7 cells in comparison to commercial LD and also displayed better results in the cytotoxicity and apoptosis/necrosis assays in comparison to CD-LMM.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
